Boston Scientific | BSX - Assets


Boston Scientific reported $45.22B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
CONMED USD 2.3B 14.64M Jun/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Dexcom USD 6.46B 178M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.86B 144.34M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026